QIRYAT SHMONA, ISRAEL, May 31, 2022 /EINPresswire.com/ — MigVax Ltd., a start-up developing an oral subunit vaccine against COVID-19, today announced that it has appointed Ran Amir as its new CEO. David Zigdon, MigVax’s first CEO and CEO of the MIGAL Galilee Research Institute, will continue playing an active role as MigVax’s President and Member of the Board of Directors.

Read more here.